Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000179297 | SCV000231523 | benign | not specified | 2014-12-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001084474 | SCV000284791 | benign | Familial hypocalciuric hypercalcemia; Autosomal dominant hypocalcemia 1 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000711037 | SCV000841357 | benign | not provided | 2017-12-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000711037 | SCV000971165 | likely benign | not provided | 2018-03-30 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV004020143 | SCV001177376 | likely benign | Nephrolithiasis/nephrocalcinosis | 2019-02-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV002256096 | SCV002531534 | benign | Hereditary cancer-predisposing syndrome | 2020-09-01 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000179297 | SCV002550435 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing |